Characterization of an immunosuppressive anti-CD40 ligand monoclonal antibody

被引:4
|
作者
Kim, KM
Min, HY
Jung, SH
Lee, TH
Kim, JG
Kang, CY [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Immunol Lab, Seoul 151742, South Korea
[2] Yonsei Univ, Dept Biol, Seoul 120749, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul 110799, South Korea
来源
HYBRIDOMA | 1998年 / 17卷 / 05期
关键词
D O I
10.1089/hyb.1998.17.463
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The interaction between CD40 ligand (CD40L) and its counter-receptor CD40 is critically important in T- and B-cell costimulation and generation of the humoral immune response. But several questions still remain unsolved, particularly in the human in vivo system. To clarify the precise function of CD40L and develop an immunosuppressive agent, we have generated a murine monoclonal antibody (MAb), 2B2 specific for human CD40L, The specificity of this MAb for human CD40L was verified by enzyme-linked immunoadsorbent assay (ELISA) and flow cytometry, MAb 2B2 immunoprecipitated proteins of molecular weight 35 and 28 kD on human peripheral blood lymphocytes (PBLs) stimulated with phorbol 12-myristate-13-acetate (PMA) plus ionomycin, Then we have studied the biological effect of MAb 2B2 in severe combined immunodeficiency (SCID) mice reconstituted with human PBLs, The data showed that this MAb strongly suppressed human IgG production of human B cells transplanted in SCID mice, indicating that this MAb 2B2 could be used to regulate unwanted immune responses associated with autoimmune disease. Then we analyzed the sequence of MAb 2B2, The 2B2 heavy chain variable region (VH) and light chain variable region (V-L) genes were cloned using PCR, The cloned V-H gene coded for 123 amino acid residues and belonged to the subgroup III(D), The V-L gene coded for 126 amino acid and-belonged to the subgroup V, Collectively, these results will be used to develop an immunosuppressive chimeric or humanized anti-CD40L antibody.
引用
收藏
页码:463 / 470
页数:8
相关论文
共 50 条
  • [1] Anti-CD40 monoclonal antibody
    Geldart, T
    Illidge, T
    LEUKEMIA & LYMPHOMA, 2005, 46 (08) : 1105 - 1113
  • [2] Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis
    Tanaka, H.
    Yang, G. -X.
    Iwakoshi, N.
    Knechtle, S. J.
    Kawata, K.
    Tsuneyama, K.
    Leung, P.
    Coppel, R. L.
    Ansari, A. A.
    Joh, T.
    Bowlus, C.
    Gershwin, M. E.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 174 (03): : 364 - 371
  • [3] In Vivo Characterization of a Novel Recombinant Anti-CD40 Monoclonal Antibody in Nonhuman Primates
    Badell, I. R.
    Mendel, J. B.
    Robertson, J. M.
    Johnson, B. E.
    Wang, X.
    Wang, R.
    Iwakoshi, N. N.
    Reimann, K. A.
    Kirk, A. D.
    Larsen, Christian P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 214 - 214
  • [4] Characterization of a Broadly Reactive Anti-CD40 Agonistic Monoclonal Antibody for Potential Use as an Adjuvant
    Martin, Cameron
    Waghela, Suryakant D.
    Lokhandwala, Shehnaz
    Ambrus, Andy
    Bray, Jocelyn
    Vuong, Christina
    Vinodkumar, Vanitha
    Dominowski, Paul J.
    Rai, Sharath
    Mwangi, Duncan
    Foss, Dennis L.
    Mwangi, Waithaka
    PLOS ONE, 2017, 12 (01):
  • [5] Use of anti-CD40 ligand monoclonal antibody as antirejection therapy in a murine peripheral nerve allograft model
    Jensen, JN
    Tung, THH
    Mackinnon, SE
    Brenner, MJ
    Hunter, DA
    MICROSURGERY, 2004, 24 (04) : 309 - 315
  • [6] Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody
    Namba, K
    Ogasawara, K
    Kitaichi, N
    Morohashi, T
    Sasamoto, Y
    Kotake, S
    Matsuda, H
    Iwabuchi, K
    Iwabuchi, C
    Ohno, S
    Onoé, K
    JOURNAL OF IMMUNOLOGY, 2000, 165 (06): : 2962 - 2969
  • [7] Anti-CD40 ligand monoclonal antibody induces a permissive state, but not tolerance, for murine peripheral nerve allografts
    Brenner, MJ
    Tung, THH
    Mackinnon, SE
    Myckatyn, TM
    Hunter, DA
    Mohanakumar, T
    EXPERIMENTAL NEUROLOGY, 2004, 186 (01) : 59 - 69
  • [8] Anti-CD40 monoclonal antibody ameliorates experimental autoimmune uveoretinitis in mice
    Xu, Lei
    Gao, Jie
    Pan, Yongquan
    Tian, Na
    He, Mingzhong
    Jin, Lei
    Chen, Feilan
    VETERINARY OPHTHALMOLOGY, 2020, 23 (05) : 797 - 805
  • [9] Anti-CD40 ligand antibody and anti-CD40 isotype IgG2B antibody induce equivalent murine chimerism and skin graft tolerance unlike anti-CD40 isotype IgG1 antibody.
    Milas, ZL
    Adams, AB
    Jones, T
    Durham, M
    Pearson, TC
    Larsen, CP
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 581 - 581
  • [10] Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40
    Law, CL
    Gordon, KA
    Collier, J
    Klussman, K
    McEarchern, JA
    Cerveny, CG
    Mixan, BJ
    Lee, WP
    Lin, ZH
    Valdez, P
    Wahl, AF
    Grewal, IS
    CANCER RESEARCH, 2005, 65 (18) : 8331 - 8338